These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Immobilization of recombinant lysostaphin on nanoparticle through biotin-streptavidin conjugation technology as a geometrical progressed confrontation against Staphylococcus aureus infection. Ehsani G; Farahnak M; Norouzian D; Ehsani P Biotechnol Appl Biochem; 2021 Oct; 68(5):1058-1066. PubMed ID: 32918836 [TBL] [Abstract][Full Text] [Related]
23. Lysostaphin-coated catheters eradicate Staphylococccus aureus challenge and block surface colonization. Shah A; Mond J; Walsh S Antimicrob Agents Chemother; 2004 Jul; 48(7):2704-7. PubMed ID: 15215130 [TBL] [Abstract][Full Text] [Related]
24. Effect of cooperation of chaperones and gene dosage on the expression of porcine PGLYRP-1 in Pichia pastoris. Yang J; Lu Z; Chen J; Chu P; Cheng Q; Liu J; Ming F; Huang C; Xiao A; Cai H; Zhang L Appl Microbiol Biotechnol; 2016 Jun; 100(12):5453-65. PubMed ID: 26883349 [TBL] [Abstract][Full Text] [Related]
26. Enhanced expression of lipase I from Galactomyces geotrichum by codon optimisation in Pichia pastoris. Qiao H; Zhang W; Guan W; Chen F; Zhang S; Deng Z Protein Expr Purif; 2017 Oct; 138():34-45. PubMed ID: 28583876 [TBL] [Abstract][Full Text] [Related]
27. Role of Naranjo CA; Jivan AD; Vo MN; de Sa Campos KH; Deyarmin JS; Hekman RM; Uribe C; Hang A; Her K; Fong MM; Choi JJ; Chou C; Rabara TR; Myers G; Moua P; Thor D; Risser DD; Vierra CA; Franz AH; Lin-Cereghino J; Lin-Cereghino GP Appl Environ Microbiol; 2019 Dec; 85(24):. PubMed ID: 31585990 [TBL] [Abstract][Full Text] [Related]
28. In vitro activity of recombinant lysostaphin-antibiotic combinations toward methicillin-resistant Staphylococcus aureus. Polak J; Della Latta P; Blackburn P Diagn Microbiol Infect Dis; 1993; 17(4):265-70. PubMed ID: 8112040 [TBL] [Abstract][Full Text] [Related]
29. Codon optimization, promoter and expression system selection that achieved high-level production of Yarrowia lipolytica lipase in Pichia pastoris. Zhou WJ; Yang JK; Mao L; Miao LH Enzyme Microb Technol; 2015 Apr; 71():66-72. PubMed ID: 25765312 [TBL] [Abstract][Full Text] [Related]
30. Lysostaphin and BMP-2 co-delivery reduces Johnson CT; Sok MCP; Martin KE; Kalelkar PP; Caplin JD; Botchwey EA; GarcĂa AJ Sci Adv; 2019 May; 5(5):eaaw1228. PubMed ID: 31114804 [No Abstract] [Full Text] [Related]
31. Protein expression and purification of human Zbtb7A in Pichia pastoris via gene codon optimization and synthesis. Wang H; Wang Q; Zhang F; Huang Y; Ji Y; Hou Y Protein Expr Purif; 2008 Aug; 60(2):97-102. PubMed ID: 18482847 [TBL] [Abstract][Full Text] [Related]
32. In vivo efficacy of the antimicrobial peptide ranalexin in combination with the endopeptidase lysostaphin against wound and systemic meticillin-resistant Staphylococcus aureus (MRSA) infections. Desbois AP; Gemmell CG; Coote PJ Int J Antimicrob Agents; 2010 Jun; 35(6):559-65. PubMed ID: 20206480 [TBL] [Abstract][Full Text] [Related]
33. Design and High Expression of Non-glycosylated Lysostaphins in Shen W; Yang N; Teng D; Hao Y; Ma X; Mao R; Wang J Front Microbiol; 2021; 12():637662. PubMed ID: 33815324 [TBL] [Abstract][Full Text] [Related]
34. Cloning and characterization in Pichia pastoris of PNO1 gene required for phosphomannosylation of N-linked oligosaccharides. Miura M; Hirose M; Miwa T; Kuwae S; Ohi H Gene; 2004 Jan; 324():129-37. PubMed ID: 14693378 [TBL] [Abstract][Full Text] [Related]
35. Engineering the Pichia pastoris N-Glycosylation Pathway Using the GlycoSwitch Technology. Laukens B; De Wachter C; Callewaert N Methods Mol Biol; 2015; 1321():103-22. PubMed ID: 26082218 [TBL] [Abstract][Full Text] [Related]
36. Genome-scale metabolic model of Pichia pastoris with native and humanized glycosylation of recombinant proteins. Irani ZA; Kerkhoven EJ; Shojaosadati SA; Nielsen J Biotechnol Bioeng; 2016 May; 113(5):961-9. PubMed ID: 26480251 [TBL] [Abstract][Full Text] [Related]
37. epr, which encodes glycylglycine endopeptidase resistance, is homologous to femAB and affects serine content of peptidoglycan cross bridges in Staphylococcus capitis and Staphylococcus aureus. Sugai M; Fujiwara T; Ohta K; Komatsuzawa H; Ohara M; Suginaka H J Bacteriol; 1997 Jul; 179(13):4311-8. PubMed ID: 9209049 [TBL] [Abstract][Full Text] [Related]
38. Antibody-directed targeting of lysostaphin adsorbed onto polylactide nanoparticles increases its antimicrobial activity against S. aureus in vitro. Satishkumar R; Vertegel AA Nanotechnology; 2011 Dec; 22(50):505103. PubMed ID: 22107797 [TBL] [Abstract][Full Text] [Related]
39. Surface disinfection properties of the combination of an antimicrobial peptide, ranalexin, with an endopeptidase, lysostaphin, against methicillin-resistant Staphylococcus aureus (MRSA). Desbois AP; Lang S; Gemmell CG; Coote PJ J Appl Microbiol; 2010 Feb; 108(2):723-30. PubMed ID: 19709343 [TBL] [Abstract][Full Text] [Related]
40. Expression of codon optimized human bone morphogenetic protein 4 in Pichia pastoris. Huang Y; Zhen B; Lin Y; Cai Y; Lin Z; Deng C; Zhang Y Biotechnol Appl Biochem; 2014; 61(2):175-83. PubMed ID: 23941573 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]